References
Sorrentino D (2013) State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. Nat Rev Gastroenterol Hepatol 10:413–422
Schwartz M, Regueiro M (2011) Prevention and treatment of postoperative Crohn’s disease recurrence: an update for a new decade. Curr Gastroenterol Rep 13:95–100
Vuitton L, Koch S, Peyrin-Biroulet L (2013) Preventing postoperative recurrence in Crohn’s disease: what does the future hold? Drugs 73:1749–1759
Peyrin-Biroulet L, Oussalah A, Roblin X et al (2011) The use of azathioprine in Crohn’s disease during pregnancy and in the post-operative setting: a worldwide survey of experts. Aliment Pharmacol Ther 33:707–713
Conflicts of interest
D. Sorrentino has acted as a consultant for the following companies/organizations: Abbott Laboratories, AstraZeneca, Centocor, Ferring Pharmaceuticals, Giuliani SpA, Hoffmann LaRoche, Janssen, MSD, Schering–Plough Corporation. P.M. Robb has no disclosures. This work was not supported by the pharmaceutical industry.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robb, P.M., Sorrentino, D. Long-term prevention of postoperative Crohn’s disease recurrence with azathioprine: the wolf in the sheep clothing. Int J Colorectal Dis 30, 283–284 (2015). https://doi.org/10.1007/s00384-014-1984-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-014-1984-x